These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation. Sangomla S; Saifi MA; Khurana A; Godugu C J Trace Elem Med Biol; 2018 May; 47():53-62. PubMed ID: 29544808 [TBL] [Abstract][Full Text] [Related]
3. Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice. Guenancia C; Li N; Hachet O; Rigal E; Cottin Y; Dutartre P; Rochette L; Vergely C Toxicol Appl Pharmacol; 2015 Apr; 284(2):152-62. PubMed ID: 25711856 [TBL] [Abstract][Full Text] [Related]
4. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Koleini N; Kardami E Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146 [TBL] [Abstract][Full Text] [Related]
5. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy. Zhang QL; Yang JJ; Zhang HS Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094 [TBL] [Abstract][Full Text] [Related]
6. Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2. Zhou L; Li R; Liu C; Sun T; Htet Aung LH; Chen C; Gao J; Zhao Y; Wang K Free Radic Biol Med; 2017 Mar; 104():360-370. PubMed ID: 28137654 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress injury in doxorubicin-induced cardiotoxicity. Songbo M; Lang H; Xinyong C; Bin X; Ping Z; Liang S Toxicol Lett; 2019 Jun; 307():41-48. PubMed ID: 30817977 [TBL] [Abstract][Full Text] [Related]
8. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. Working PK; Newman MS; Sullivan T; Yarrington J J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696 [TBL] [Abstract][Full Text] [Related]
10. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity. Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227 [TBL] [Abstract][Full Text] [Related]
11. Novel molecular mechanisms of doxorubicin cardiotoxicity: latest leading-edge advances and clinical implications. Robert Li Y; Traore K; Zhu H Mol Cell Biochem; 2024 May; 479(5):1121-1132. PubMed ID: 37310587 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis. Abe K; Ikeda M; Ide T; Tadokoro T; Miyamoto HD; Furusawa S; Tsutsui Y; Miyake R; Ishimaru K; Watanabe M; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H Sci Signal; 2022 Nov; 15(758):eabn8017. PubMed ID: 36318618 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity. Wu BB; Leung KT; Poon EN Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163838 [TBL] [Abstract][Full Text] [Related]
14. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways. Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534 [TBL] [Abstract][Full Text] [Related]
15. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis. Shaker RA; Abboud SH; Assad HC; Hadi N BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Carvalho FS; Burgeiro A; Garcia R; Moreno AJ; Carvalho RA; Oliveira PJ Med Res Rev; 2014 Jan; 34(1):106-35. PubMed ID: 23494977 [TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ. He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment. Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096 [TBL] [Abstract][Full Text] [Related]
20. p-Coumaric acid mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy. Sunitha MC; Dhanyakrishnan R; PrakashKumar B; Nevin KG Biomed Pharmacother; 2018 Jun; 102():823-832. PubMed ID: 29605770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]